Diaverum’s €900m refi loan still in the works

Diaverum, the Swedish dialysis clinic operator, is making slow progress on a planned €900m refinancing loan. The launch is not expected until at least March.

  • By Olivier Holmey
  • 14 Feb 2014

There has been talk of the deal at least since early January, but one senior source said the plans had hardly progressed since then.

JP Morgan, which is involved in the deal, was reportedly hired over a year ago by the company’s private equity owner Bridgepoint to review ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 20 Mar 2017
1 Bank of America Merrill Lynch 3,452.47 11 8.55%
2 Goldman Sachs 3,349.08 10 8.29%
3 JPMorgan 3,343.06 8 8.28%
4 Credit Suisse 2,505.48 12 6.20%
5 Deutsche Bank 2,382.73 14 5.90%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 Citi 2,417.98 11 10.88%
2 Deutsche Bank 2,229.13 17 10.03%
3 Bank of America Merrill Lynch 1,908.90 13 8.59%
4 JPMorgan 1,733.98 11 7.80%
5 Barclays 1,569.70 11 7.06%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 JPMorgan 11,150.67 77 12.59%
2 Citi 8,073.45 55 9.11%
3 Bank of America Merrill Lynch 7,652.39 65 8.64%
4 Goldman Sachs 6,155.05 45 6.95%
5 Credit Suisse 5,502.63 40 6.21%